LIMAA develops a fully automated tissue preserving end-to-end histopathology platform for clinical use. This first of its kind platform allows to analyze entire tissue biospecimens in 2D and 3D without embedding or slicing while the tissue is not consumed. Preserved tissue samples are used for downstream applications leading to the unique opportunity to integrate multiplex biomarker visualization of entire tissue samples, genomics and AI guided decision making in every routine sample – no matter what sample size.